These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6595483

  • 41. Kinetics of normal hemopoietic stem cells during leukemia growth before and after induction of a complete remission. Studies in a rat model for acute myelocytic leukemia (BNML).
    Martens AC, Hagenbeek A.
    Leuk Res; 1987; 11(5):453-9. PubMed ID: 3472017
    [Abstract] [Full Text] [Related]

  • 42. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE, Straus MJ.
    Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
    [Abstract] [Full Text] [Related]

  • 43. Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.
    Avramis VI, Wiersma S, Krailo MD, Ramilo-Torno LV, Sharpe A, Liu-Mares W, Kowck R, Reaman GH, Sato JK.
    Clin Cancer Res; 1998 Jan; 4(1):45-52. PubMed ID: 9516951
    [Abstract] [Full Text] [Related]

  • 44. Recombinant human granulocyte colony-stimulating factor enhanced cytotoxicity of Ara-C in Ara-C-resistant leukemic cells from a patient with biphenotypic leukemia in cell kinetic quiescence.
    Higashigawa M, Komada Y, Washio N, Kuwabara H, Hori H, Ido M, Sakurai M.
    Leuk Res; 1992 Oct; 16(10):1049-54. PubMed ID: 1383642
    [Abstract] [Full Text] [Related]

  • 45. Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia.
    Lishner M, Curtis JE, Minkin S, McCulloch EA.
    Leukemia; 1989 Nov; 3(11):784-8. PubMed ID: 2811479
    [Abstract] [Full Text] [Related]

  • 46. Cell kinetics after high dose cytosine arabinoside in patients with acute myelocytic leukemia.
    Colly LP, Peters WG, Arentsen-Honders MW, Willemze R.
    Blut; 1990 Feb; 60(2):76-80. PubMed ID: 2302466
    [Abstract] [Full Text] [Related]

  • 47. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA, Löwenberg B, Sonneveld P.
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [Abstract] [Full Text] [Related]

  • 48. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J.
    Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678
    [Abstract] [Full Text] [Related]

  • 49. In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells.
    Chan CS, Schechter GP.
    Cancer Chemother Pharmacol; 1989 Jun 15; 23(2):87-94. PubMed ID: 2910516
    [Abstract] [Full Text] [Related]

  • 50. Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.
    el-Beltagi HM, Martens AC, Dahab GM, Hagenbeek A.
    Leukemia; 1993 Nov 15; 7(11):1795-800. PubMed ID: 8231248
    [Abstract] [Full Text] [Related]

  • 51. Combined effect of cytosine arabinoside and thiopurines.
    Valeriote F, Vietti T, Edelstein M.
    Cancer Treat Rep; 1976 Dec 15; 60(12):1925-34. PubMed ID: 1026347
    [Abstract] [Full Text] [Related]

  • 52. BCG treatment of residual disease in acute leukemia: studies in a rat model for human acute myelocytic leukemia (BNML).
    Hagenbeek A, Martens AC.
    Leuk Res; 1983 Dec 15; 7(4):547-55. PubMed ID: 6578394
    [Abstract] [Full Text] [Related]

  • 53. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C.
    Exp Hematol; 1991 May 15; 19(4):267-72. PubMed ID: 2055291
    [Abstract] [Full Text] [Related]

  • 54. Use of liquid culture and cell cycle analysis to compare drug damage following in vitro treatment of normal human bone marrow cells with adriamycin, arabinosyl-cytosine, and etoposide.
    Cavazzana M, Calvo F, Facchin P, Barreau P, Geny B, Dal Cortivo L, Dresch C.
    Exp Hematol; 1988 Nov 15; 16(10):876-83. PubMed ID: 3169155
    [Abstract] [Full Text] [Related]

  • 55. Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.
    Grant S, Bhalla K, Gleyzer M.
    Leuk Res; 1986 Nov 15; 10(9):1139-46. PubMed ID: 2429121
    [Abstract] [Full Text] [Related]

  • 56. FLT3-ITD drives Ara-C resistance in leukemic cells via the induction of RUNX3.
    Damdinsuren A, Matsushita H, Ito M, Tanaka M, Jin G, Tsukamoto H, Asai S, Ando K, Miyachi H.
    Leuk Res; 2015 Dec 15; 39(12):1405-13. PubMed ID: 26475207
    [Abstract] [Full Text] [Related]

  • 57. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug 15; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

  • 58. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA, DiCarlo J, Groshek P, Kanakura Y, Berg D, Mayer RJ, Griffin JD.
    Leukemia; 1991 Mar 15; 5(3):230-8. PubMed ID: 1826536
    [Abstract] [Full Text] [Related]

  • 59. The effect of cantharidins on leukemic stem cells.
    Dorn DC, Kou CA, Png KJ, Moore MA.
    Int J Cancer; 2009 May 01; 124(9):2186-99. PubMed ID: 19123473
    [Abstract] [Full Text] [Related]

  • 60. Low-dose Ara-C in the treatment of acute leukemia. Cytotoxicity or differentiation induction?
    Hoelzer D, Ganser A, Anger B, Seifried E, Heimpel H.
    Blut; 1984 Apr 01; 48(4):233-8. PubMed ID: 6585240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.